We serve Chemical Name:(1S)-2,2-Dimethylcyclopropanecarboxamide CAS:75885-58-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(1S)-2,2-Dimethylcyclopropanecarboxamide
CAS.NO:75885-58-4
Synonyms:(1S)-2,2-Dimethylcyclopropanecarboxamide;MFCD00216614;Cyclopropanecarboxamide, 2,2-dimethyl-, (1S)-;L3TJ A1 A1 BVZ &&S Form;(1S)-2,2-dimethylcyclopropane-1-carboxamide;6890220;EINECS 278-334-3
Molecular Formula:C6H11NO
Molecular Weight:113.158
HS Code:2924299090
Physical and Chemical Properties:
Melting point:135-137ºC
Boiling point:225.1±7.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.480
PSA:43.09000
Exact Mass:113.084061
LogP:0.17
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like (1S)-2,2-Dimethylcyclopropanecarboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 278-334-3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyclopropanecarboxamide, 2,2-dimethyl-, (1S)- Use and application,S Form technical grade,usp/ep/jp grade.
Related News: CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 34,84-heptadecaoxidane-3,8-dione manufacturers A new post-hoc analysis of pooled data from the TULIP phase III clinical trials being presented at the annual European Congress of Rheumatology (EULAR 2021) showed anifrolumab was consistently associated with improvements in both skin rash and arthritis across three different disease measures each, compared to placebo, in patients with moderate to severe systemic lupus erythematosus (SLE). meso-5,6-di-tert-butyl-2,2,9,9-tetramethyl-decane-3,8-dione suppliers The booster campaign, with shots administered by health maintenance organisations, will effectively turn Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration (FDA). 3-[{6-[Bis-(2-pyridin-2-yl-ethyl)-amino]-hexyl}-(2-pyridin-2-yl-ethyl)-amino]-propionitrile vendor & factory.
